BIOMAT Database Logo BIOMAT Database Logo

[Modern treatment of diabetes mellitus with sulfonylurea compounds]. 1979

H Haller, and M Hanefeld, and W Leonhardt

UI MeSH Term Description Entries
D006951 Hyperlipoproteinemias Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation. Hyperlipoproteinemia
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea

Related Publications

H Haller, and M Hanefeld, and W Leonhardt
Treatment of chemical diabetes mellitus with sulfonylurea compounds.
February 1973, Metabolism: clinical and experimental,
H Haller, and M Hanefeld, and W Leonhardt
[Combined treatment of diabetes mellitus with insulin and sulfonylurea compounds (SU)].
April 1970, Die Medizinische Welt,
H Haller, and M Hanefeld, and W Leonhardt
[Simplified combination treatment of diabetes mellitus with sulfonylurea compounds and biguanides].
January 1975, Zeitschrift fur Allgemeinmedizin,
H Haller, and M Hanefeld, and W Leonhardt
Acetohexamide: comparison with other sulfonylurea compounds in the treatment of diabetes mellitus.
January 1962, Clinical pharmacology and therapeutics,
H Haller, and M Hanefeld, and W Leonhardt
Comparison of acetohexamide with other sulfonylurea compounds in the treatment of diabetes mellitus.
December 1965, Acta medica Scandinavica,
H Haller, and M Hanefeld, and W Leonhardt
Clinical use of oral sulfonylurea compounds in diabetes mellitus.
January 1957, Quarterly bulletin. Northwestern University (Evanston, Ill.). Medical School,
H Haller, and M Hanefeld, and W Leonhardt
Sulfonylurea treatment of insulin-independent diabetes mellitus.
May 1980, Metabolism: clinical and experimental,
H Haller, and M Hanefeld, and W Leonhardt
[Therapy of diabetes mellitus in "secondary failure of sulfonylurea compounds"].
June 1987, Medizinische Klinik (Munich, Germany : 1983),
H Haller, and M Hanefeld, and W Leonhardt
[Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
July 1969, Arzneimittel-Forschung,
H Haller, and M Hanefeld, and W Leonhardt
[Complications in oral treatment of diabetes mellitus with sulfonylurea derivatives].
January 1960, Ugeskrift for laeger,
Copied contents to your clipboard!